How Can Biopharma Companies Best Prevent Prescription Drug Abuse?

September 9, 2019

The misuse of prescription drugs for non-medical purposes has become an increasing problem worldwide. Together with Evotec, we have taken a look at how biopharma companies can prevent prescription drug abuse by taking drugs through strict assessment processes.

Spotlight

SAJA Pharmaceuticals

SAJA is a joint venture between the premier Saudi healthcare company, Tamer, the Saudi partner, the (SA) in SAJA and two of the leading Japanese pharmaceutical companies, Daiichi Sankyo Co., Ltd. and Astellas Pharma Inc., the Japanese partners, the (JA) in SAJA. Both companies are major players in the Japanese healthcare sector, each with an impressive portfolio of ethical medicines.

Other Infographics
news image

What Does The Pharma IndustryWant From CROs?

Infographic | June 16, 2022

Use Informa Pharma Intelligence’s marketing and pharma expertise to conduct industry research, produce engaging thought leadership content,

Read More
news image

Do patients actually watch all those pharma TV ads?

Infographic | January 13, 2020

Fewer than one in eight chronic-disease sufferers say they watch when a drug commercial comes on TV, according to one recent study of community users. And for the millennials among them, the percentage is even less so. That’s despite the $5.1 billion spent by biopharma on the medium in 2018. We take a look at these data points and many others from two recent studies on the media habits of patients and doctors.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More
news image

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Read More
news image

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Read More
news image

COVID-19 Summary as of March 13, 2020

Infographic | April 6, 2020

Biomedtracker and Trialtrove have a total of 307 clinical trials for the treatment of COVID-19. 152 initiated trials for the treatment of COVID-19. 155 Trials have been announced but have not yet begun recruitment.

Read More

Spotlight

SAJA Pharmaceuticals

SAJA is a joint venture between the premier Saudi healthcare company, Tamer, the Saudi partner, the (SA) in SAJA and two of the leading Japanese pharmaceutical companies, Daiichi Sankyo Co., Ltd. and Astellas Pharma Inc., the Japanese partners, the (JA) in SAJA. Both companies are major players in the Japanese healthcare sector, each with an impressive portfolio of ethical medicines.

Events